title: Expression of MAGE, gp100 and tyrosinase genes in uveal melanoma cell lines.
abstract: In order to determine the possible use of uveal melanoma cell lines as stimulators in immunotherapy, we evaluated the expression of the human genes for MAGE-1, -2 and -3, gp100 and tyrosinase in uveal melanoma cell lines. mRNA expression of the MAGE-1, -2 and -3, gp100 and tyrosinase genes and the HLA class I specificity were determined in five primary and three metastatic uveal melanoma cell lines. Expression of the examined genes was heterogeneous in the primary and metastatic cell lines. The cell lines OCM-1 and OMM-1 expressed MAGE-1, -2 and -3, whereas EOM-3, MEL202, 92-1 and OMM-3 were negative for these antigens. gp100 was expressed in all cell lines, and tyrosinase in all but three (EOM-29, OMM-2 and OMM-3). Except for EOM-3, the HLA-A type of all the cell lines could be determined by complement-dependent microlymphocytotoxicity assay. Since at least two melanoma-associated antigens can be found in uveal melanoma cell lines, as well as the HLA class I molecules, these cell lines may be applicable as immunogens for specific immunotherapy against metastatic uveal melanoma.
authors.affiliation: Department of Ophthalmology, Erasmus University Rotterdam, The Netherlands. Luyten@ipr.nl
authors.forename: G P
authors.initials: GP
authors.lastname: Luyten
authors.forename: C W
authors.initials: CW
authors.lastname: van der Spek
authors.forename: I
authors.initials: I
authors.lastname: Brand
authors.forename: K
authors.initials: K
authors.lastname: Sintnicolaas
authors.forename: I
authors.initials: I
authors.lastname: de Waard-Siebinga
authors.forename: M J
authors.initials: MJ
authors.lastname: Jager
authors.forename: P T
authors.initials: PT
authors.lastname: de Jong
authors.forename: P I
authors.initials: PI
authors.lastname: Schrier
authors.forename: T M
authors.initials: TM
authors.lastname: Luider
mesh_terms: D000951:Antigens, Neoplasm; D003601:Cytotoxicity Tests, Immunologic; D017931:DNA Primers / Q000737:chemistry; D015234:HLA-A Antigens / Q000378:metabolism; D006801:Humans; D008545:Melanoma / Q000378:metabolism*; D058950:Melanoma-Specific Antigens; D008562:Membrane Glycoproteins / Q000235:genetics / Q000378:metabolism*; D014442:Monophenol Monooxygenase / Q000235:genetics / Q000378:metabolism*; D009363:Neoplasm Proteins / Q000235:genetics / Q000378:metabolism*; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000378:metabolism; D014407:Tumor Cells, Cultured; D014604:Uveal Neoplasms / Q000378:metabolism*; D058951:gp100 Melanoma Antigen
chemical_list: D000951:Antigens, Neoplasm; D017931:DNA Primers; D015234:HLA-A Antigens; C072011:MAGEA1 protein, human; C072013:MAGEA3 protein, human; C072012:MAGEB2 protein, human; D058950:Melanoma-Specific Antigens; D008562:Membrane Glycoproteins; D009363:Neoplasm Proteins; C548637:PMEL protein, human; D012333:RNA, Messenger; D058951:gp100 Melanoma Antigen; D014442:Monophenol Monooxygenase